ESR1 and breast cancer: Currently it is not known if such sexual dimorphism in angiogenesis plays a role in CRC development although there is evidence that the non-genomic membrane ER effects of estrogen on EC biology do not translate into proliferative effects in uterine or breast cancers (143).